Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Furaprevir [inn]
2. Tg-2349
3. 0umm44reu9
4. 1435923-88-8
5. Unii-0umm44reu9
6. Tg 2349
7. Furaprevir [who-dd]
8. Schembl6857175
9. Chembl4297647
10. Glxc-25529
11. Db12785
12. Q27237271
13. Cyclopentyl N-[(1s,4r,6s,7z,14s,18r)-4-[(1-methylcyclopropyl)sulfonylcarbamoyl]-2,15-dioxo-18-[[2-(4-propan-2-yloxyphenyl)-[1]benzofuro[3,2-d]pyrimidin-4-yl]oxy]-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate
| Molecular Weight | 897.0 g/mol |
|---|---|
| Molecular Formula | C47H56N6O10S |
| XLogP3 | 7.3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 11 |
| Exact Mass | 896.37786318 g/mol |
| Monoisotopic Mass | 896.37786318 g/mol |
| Topological Polar Surface Area | 217 Ų |
| Heavy Atom Count | 64 |
| Formal Charge | 0 |
| Complexity | 1860 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
73
PharmaCompass offers a list of Furaprevir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Furaprevir manufacturer or Furaprevir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Furaprevir manufacturer or Furaprevir supplier.
PharmaCompass also assists you with knowing the Furaprevir API Price utilized in the formulation of products. Furaprevir API Price is not always fixed or binding as the Furaprevir Price is obtained through a variety of data sources. The Furaprevir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Furaprevir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Furaprevir, including repackagers and relabelers. The FDA regulates Furaprevir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Furaprevir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Furaprevir supplier is an individual or a company that provides Furaprevir active pharmaceutical ingredient (API) or Furaprevir finished formulations upon request. The Furaprevir suppliers may include Furaprevir API manufacturers, exporters, distributors and traders.
Furaprevir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Furaprevir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Furaprevir GMP manufacturer or Furaprevir GMP API supplier for your needs.
A Furaprevir CoA (Certificate of Analysis) is a formal document that attests to Furaprevir's compliance with Furaprevir specifications and serves as a tool for batch-level quality control.
Furaprevir CoA mostly includes findings from lab analyses of a specific batch. For each Furaprevir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Furaprevir may be tested according to a variety of international standards, such as European Pharmacopoeia (Furaprevir EP), Furaprevir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Furaprevir USP).